JODY SPAIN: Open Payments
NPI 1427364744 · POPLAR BLUFF, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$301 in 17 payments from 11 companies in 2025. Trend: 2023 $207 · 2024 $565 · 2025 $301
Food & beverage: $301
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 3 | $71 |
| Organon LLC | 3 | $42 |
| Dexcom, Inc. | 2 | $40 |
| Exeltis, USA Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $21 |
| Amgen Inc. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $18 |
| Radius Health, Inc. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $16 |
Products named: MYFEMBREE, Dexcom G6 Transmitter, NEXPLANON, SLYND, Wegovy, EVENITY, Mirena, Tymlos.
Industry payments across MO — which companies pay providers there.
